98 related articles for article (PubMed ID: 24394032)
1. [Analysis of weekly paclitaxel chemotherapy for esophageal cancer].
Kawada J; Nishimura M; Matsui Y; Nomura M; Noguchi Y; Okumura Y; Danno K; Kubota M; Matsuda C; Omori K; Nishikawa K; Nomura M; Takagi M; Fukui A; Fujitani K; Iwase K; Tanaka Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2118-20. PubMed ID: 24394032
[TBL] [Abstract][Full Text] [Related]
2. A retrospective comparison of docetaxel and paclitaxel for patients with advanced or recurrent esophageal cancer who previously received platinum-based chemotherapy.
Mizota A; Shitara K; Kondo C; Nomura M; Yokota T; Takahari D; Ura T; Muro K
Oncology; 2011; 81(3-4):237-42. PubMed ID: 22094594
[TBL] [Abstract][Full Text] [Related]
3. Salvage weekly paclitaxel in recurrent ovarian cancer.
Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy.
Brenner B; Ilson DH; Minsky BD; Bains MS; Tong W; Gonen M; Kelsen DP
J Clin Oncol; 2004 Jan; 22(1):45-52. PubMed ID: 14701767
[TBL] [Abstract][Full Text] [Related]
5. Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer: a preliminary study.
Nishio S; Ota S; Sugiyama T; Matsuo G; Kawagoe H; Kumagai S; Ushijima K; Nishida T; Kamura T
Int J Clin Oncol; 2003 Feb; 8(1):45-8. PubMed ID: 12601542
[TBL] [Abstract][Full Text] [Related]
6. Phase I and pharmacological study of single paclitaxel administered weekly for heavily pre-treated patients with epithelial ovarian cancer.
Takano M; Kikuchi Y; Kita T; Suzuki M; Ohwada M; Yamamoto T; Yamamoto K; Inoue H; Shimizu K
Anticancer Res; 2002; 22(3):1833-8. PubMed ID: 12168878
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Lymph Node Metastases from Esophageal Cancer Successfully Treated with Weekly Paclitaxel Chemotherapy].
Okada K; Ebisui C; Nushijima Y; Yanagisawa T; Okamura S; Fukuchi N; Murata K; Yokouchi H; Kinuta M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1926-8. PubMed ID: 26805219
[TBL] [Abstract][Full Text] [Related]
8. Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer.
Tahara M; Minami H; Hasegawa Y; Tomita K; Watanabe A; Nibu K; Fujii M; Onozawa Y; Kurono Y; Sagae D; Seriu T; Tsukuda M
Cancer Chemother Pharmacol; 2011 Sep; 68(3):769-76. PubMed ID: 21181475
[TBL] [Abstract][Full Text] [Related]
9. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L
Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of weekly paclitaxel as a second-line treatment for S-1-refractory advanced gastric cancer.
Matsuda G; Kunisaki C; Makino H; Fukahori M; Kimura J; Sato T; Oshima T; Nagano Y; Fuii S; Takagawa R; Kosaka T; Ono HA; Akiyama H; Ichikawa Y
Anticancer Res; 2009 Jul; 29(7):2863-7. PubMed ID: 19596975
[TBL] [Abstract][Full Text] [Related]
11. Single agent weekly paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: a feasibility study.
Gupta S; Bharath R; Shet T; Desai SB; Patil VM; Bakshi A; Parmar V; Badwe RA
Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):604-9. PubMed ID: 22014455
[TBL] [Abstract][Full Text] [Related]
12. Metronomic weekly paclitaxel in advanced unresectable esophageal cancer.
Noronha V; Patil V; Bhosale B; Joshi A; Purandare N; Prabhash K
Indian J Cancer; 2013; 50(2):128-34. PubMed ID: 23979204
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy.
Shirakawa T; Kato K; Nagashima K; Nishikawa A; Sawada R; Takahashi N; Shoji H; Sasaki Y; Honma Y; Iwasa S; Takashima A; Okita N; Hamaguchi T; Yamada Y; Shimada Y
Cancer Chemother Pharmacol; 2014 Dec; 74(6):1207-15. PubMed ID: 25267597
[TBL] [Abstract][Full Text] [Related]
15. Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.
Akerley W; Herndon JE; Egorin MJ; Lyss AP; Kindler HL; Savarese DM; Sherman CA; Rosen DM; Hollis D; Ratain MJ; Green MR
Cancer; 2003 May; 97(10):2480-6. PubMed ID: 12733147
[TBL] [Abstract][Full Text] [Related]
16. Weekly paclitaxel in women with heavily pretreated metastatic breast cancer: a retrospective analysis of cases treated at the Chang Gung Memorial Hospital.
Lu CH; Lin YC; Chang HK
Chang Gung Med J; 2007; 30(1):33-40. PubMed ID: 17477027
[TBL] [Abstract][Full Text] [Related]
17. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).
Glorieux P; Ortmanns P; Marien S; Degives R; Degraeve D; Potvin M; Grauwels D; Schallier D
Anticancer Res; 2001; 21(2B):1487-94. PubMed ID: 11396237
[TBL] [Abstract][Full Text] [Related]
18. Weekly paclitaxel--an effective treatment for advanced breast cancer.
Kellokumpu-Lehtinen P; Tuunanen T; Asola R; Elomaa L; Heikkinen M; Kokko R; Järvenpää R; Lehtinen I; Maiche A; Kaleva-Kerola J; Huusko M; Möykkynen K; Ala-Luhtala T
Anticancer Res; 2013 Jun; 33(6):2623-7. PubMed ID: 23749918
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer.
Ceresoli GL; Gregorc V; Cordio S; Bencardino KB; Schipani S; Cozzarini C; Bordonaro R; Villa E
Lung Cancer; 2004 May; 44(2):231-9. PubMed ID: 15084388
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson DH; Forastiere A; Arquette M; Costa F; Heelan R; Huang Y; Kelsen DP
Cancer J; 2000; 6(5):316-23. PubMed ID: 11079171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
